1.26
price down icon3.08%   -0.04
after-market After Hours: 1.26
loading

Iterum Therapeutics Plc Stock (ITRM) Forecast

The Iterum Therapeutics Plc (ITRM) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $45.92, representing a +3,544% increase from the current price of $1.26. The highest analyst price target is $43.82, and the lowest is $48.02.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ITRM Price Target
Average 47.17 (+3,644% Upside)
loading

Is Iterum Therapeutics Plc (ITRM) A Buy Now?

Oscillators
Name Value Action
RSI(14) 52.72 Neutral
STOCH(9,6) 55.28 Neutral
STOCHRSI(14) 71.04 Neutral
MACD(12,26) -0.0257 Buy
ADX(14) 35.46 Buy
William %R -39.02 Neutral
CCI(14) 72.22 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
1.158
Buy
1.1969
Buy
MA20
1.16
Buy
1.2009
Buy
MA50
1.3071
Sell
1.296
Sell
MA100
1.5513
Sell
1.3831
Sell
MA200
1.3958
Sell
1.4435
Sell
Buy: 4 Sell: 6 Neutral: 0
Summary: Sell
According to our latest analysis, ITRM could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 6 signaling Sell signals and 5 Neutral signals. This suggests that investors should exercise caution when entering new positions on ITRM, as the market is likely to remain volatile in the near term.
  1. RSI (Relative Strength Index): The RSI(14) value of 52.72 indicates that ITRM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 55.28 indicates that ITRM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 71.04 indicates that ITRM is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 35.46 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 72.22 indicates that ITRM is still overbought but not to an extreme extent.

Long-term ITRM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Iterum Therapeutics Plc financial reports and earnings history, Iterum Therapeutics Plc (ITRM) stock could reach $100.51 by 2030, $71.32 by 2040 and $229.08 by 2050. See the projected annual prices until 2050 of the Iterum Therapeutics Plc stock below:

  • Iterum Therapeutics Plc (ITRM) is expected to reach an average price of $20.26 in 2035, with a high prediction of $24.64 and a low estimate of $21.23. This indicates an $1,508% rise from the last recorded price of $1.26.
  • Iterum Therapeutics Plc (ITRM) stock is projected to chart a bullish course in 2040, with an average price target of $68.05, representing an $5,301% surge from its current level. The forecast ranges from a conservative $68.22 to a sky-high $71.32.
  • Our analysts predict Iterum Therapeutics Plc (ITRM) to jump 10,715% by 2045, soaring from $136.47 to an average price of $136.26, potentially reaching $139.87. While $136.47 is the low estimate, the potential upside is significant.
  • Iterum Therapeutics Plc (ITRM) stock is expected to climb by 2050, reaching an average of $223.56, a $17,643% jump from its current level. However, a wide range of estimates exists, with high and low targets of $229.08 and $225.36, respectively, highlighting the market's uncertainty.

Iterum Therapeutics Plc Stock (ITRM) Year by Year Forecast

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2025

Iterum Therapeutics Plc Stock (ITRM) is expected to reach an average price of $47.17 in 2025, with a high prediction of $66.69 and a low estimate of $27.65. This indicates an +3,644% rise from the last recorded price of $1.26.
Month Average Low High Change from today's price
May, 2025 $45.78 $48.02 $43.82 +3,533%
June, 2025 $31.49 $31.29 $27.13 +2,399%
July, 2025 $58.71 $27.65 $57.36 +4,559%
August, 2025 $62.27 $59.34 $61.87 +4,842%
September, 2025 $63.13 $63.63 $62.08 +4,910%
October, 2025 $67.92 $65.48 $65.86 +5,291%
November, 2025 $59.71 $66.26 $66.69 +4,639%
December, 2025 $66.62 $61.24 $65.78 +5,187%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2026

The predicted value for Iterum Therapeutics Plc (ITRM) in 2026 is set at an average of $46.48. Estimates vary from a peak of $65.59 to a trough of $27.36, indicating an +3,589% surge from the present price of $1.26.
Month Average Low High Change from today's price
January, 2026 $60.90 $64.24 $65.59 +4,733%
February, 2026 $57.52 $58.05 $60.44 +4,465%
March, 2026 $51.41 $53.66 $54.96 +3,980%
April, 2026 $36.78 $38.58 $44.52 +2,819%
May, 2026 $41.39 $43.04 $40.84 +3,185%
June, 2026 $45.25 $44.10 $42.96 +3,491%
July, 2026 $47.57 $46.91 $46.82 +3,675%
August, 2026 $33.73 $37.92 $45.27 +2,577%
September, 2026 $40.55 $27.36 $37.85 +3,118%
October, 2026 $47.17 $43.36 $46.21 +3,644%
November, 2026 $47.37 $47.67 $47.79 +3,660%
December, 2026 $47.31 $47.17 $46.73 +3,655%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Iterum Therapeutics Plc (ITRM) is $40.41, with a high forecast of $46.18 and a low forecast of $34.65. This indicates an +3,107% increase from the last price of $1.26.
Month Average Low High Change from today's price
January, 2027 $46.47 $46.48 $46.18 +3,588%
February, 2027 $45.48 $45.01 $44.46 +3,510%
March, 2027 $44.05 $44.48 $44.91 +3,396%
April, 2027 $43.94 $44.09 $43.48 +3,387%
May, 2027 $42.32 $43.26 $43.86 +3,258%
June, 2027 $41.15 $41.27 $41.57 +3,166%
July, 2027 $39.95 $39.89 $40.45 +3,071%
August, 2027 $39.68 $39.81 $39.41 +3,049%
September, 2027 $38.80 $39.16 $39.17 +2,980%
October, 2027 $37.69 $37.96 $38.21 +2,892%
November, 2027 $35.78 $36.36 $37.20 +2,740%
December, 2027 $33.74 $34.65 $34.59 +2,578%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2028

In 2028, Iterum Therapeutics Plc (ITRM) is projected to reach an average price of $26.30, with a high projection of $34.00 and a low estimate of $18.60. This indicates an +1,987% rise from the last price of $1.26.
Month Average Low High Change from today's price
January, 2028 $33.82 $33.84 $34.00 +2,584%
February, 2028 $33.25 $33.28 $33.49 +2,539%
March, 2028 $31.45 $31.49 $32.47 +2,396%
April, 2028 $30.42 $30.54 $31.06 +2,314%
May, 2028 $29.19 $29.23 $30.04 +2,217%
June, 2028 $27.45 $27.53 $28.79 +2,078%
July, 2028 $25.96 $26.02 $27.05 +1,960%
August, 2028 $24.54 $24.54 $25.57 +1,848%
September, 2028 $23.15 $23.20 $23.77 +1,737%
October, 2028 $21.61 $21.68 $22.53 +1,615%
November, 2028 $19.78 $19.84 $21.18 +1,470%
December, 2028 $18.54 $18.60 $19.36 +1,371%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2029

The 2029 price forecast for Iterum Therapeutics Plc Stock (ITRM) is $45.29 on average, with a high prediction of $90.12 and a low estimate of $0.4629. This represents an +3,495% increase from the previous price of $1.26.
Month Average Low High Change from today's price
January, 2029 $16.81 $16.85 $18.08 +1,234%
February, 2029 $15.59 $15.61 $16.45 +1,138%
March, 2029 $14.32 $14.35 $15.22 +1,036%
April, 2029 $12.95 $13.01 $13.94 +927.63%
May, 2029 $11.18 $11.26 $12.51 +787.58%
June, 2029 $8.4658 $8.7571 $9.8266 +571.89%
July, 2029 $7.2282 $7.8082 $8.0389 +473.66%
August, 2029 $5.9236 $6.0135 $6.6512 +370.12%
September, 2029 $4.8059 $4.8562 $5.4567 +281.42%
October, 2029 $2.7413 $2.8013 $4.3822 +117.56%
November, 2029 $1.5236 $1.5336 $2.3244 +20.92%
December, 2029 $101.97 $0.4629 $90.12 +7,993%

Iterum Therapeutics Plc Stock (ITRM) Price Forecast for 2030

Iterum Therapeutics Plc Stock (ITRM) is expected to reach an average price of $122.19 in 2030, with a high forecast of $148.17 and a low forecast of $96.21. This signifies an +9,598% surge from the last price of $1.26.
Month Average Low High Change from today's price
January, 2030 $92.95 $101.28 $100.51 +7,277%
February, 2030 $101.30 $106.38 $99.63 +7,940%
March, 2030 $99.40 $100.75 $99.38 +7,789%
April, 2030 $101.56 $96.21 $97.82 +7,960%
May, 2030 $105.31 $99.16 $101.26 +8,258%
June, 2030 $136.88 $122.16 $131.48 +10,764%
July, 2030 $156.51 $147.94 $147.15 +12,322%
August, 2030 $142.96 $142.13 $148.17 +11,246%
September, 2030 $119.76 $121.41 $111.75 +9,405%
October, 2030 $137.05 $130.92 $136.73 +10,777%
November, 2030 $145.02 $141.06 $136.77 +11,409%
December, 2030 $132.04 $132.88 $141.30 +10,379%
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
Cap:     |  Volume (24h):